Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

4 registered trials, newest registry update first. Showing only trials linked to Brenipatide.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
A Study of Brenipatide in Participants With Alcohol Use Disorder
NCT07219953
BrenipatidePhase 3RecruitingEli Lilly and Company1,100Apr 2028Nov 4, 2026
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
NCT07412756
BrenipatidePhase 3RecruitingEli Lilly and Company1,000Feb 2028Nov 4, 2026
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
NCT07219966
BrenipatidePhase 3RecruitingEli Lilly and Company1,100Apr 2028Oct 7, 2026
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
NCT06606106
BrenipatidePhase 1Active not recruitingEli Lilly and Company302Nov 2026Sep 30, 2026

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.